How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

OBJECTIVES: The AsseSSing Impact in pSoriatic Treatment (ASSIST) study investigated prescribing in routine PsA care and whether the patient-reported outcome-PsA Impact of Disease questionnaire (PsAID-12)-impacted treatment. This study also assessed a range of patient and clinician factors and their...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RHEUMATOLOGY 2025-01, Vol.64 (1)
Hauptverfasser: Coyle, Conor, Watson, Lily, Whately-Smith, Caroline, Brooke, Mel, Kiltz, Uta, Lubrano, Ennio, Queiro, Ruben, Trigos, David, Brandt-Juergens, Jan, Choy, Ernest, D'Angelo, Salvatore, Delle Sedie, Andrea, Dernis, Emmanuelle, Wirth, Theo, Guis, Sandrine, Helliwell, Philip, Ho, Pauline, Hueber, Axel, Joven, Beatriz, Koehm, Michaela, Morales, Carlos Montilla, Packham, Jon, Pinto Tasende, Jose Antonio, Ramirez, Julio, Ruyssen-Witrand, Adeline, Scrivo, Rossana, Twigg, Sarah, Welcker, Martin, Soubrier, Martin, Gossec, Laure, Coates, Laura C
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVES: The AsseSSing Impact in pSoriatic Treatment (ASSIST) study investigated prescribing in routine PsA care and whether the patient-reported outcome-PsA Impact of Disease questionnaire (PsAID-12)-impacted treatment. This study also assessed a range of patient and clinician factors and their relationship to PsAID-12 scoring and treatment modification. METHODS: Patients with PsA were selected across the UK and Europe between July 2021 and March 2022. Patients completed the PsAID questionnaire and the results were shared with their physician. Patient characteristics, disease activity, current treatment methods, treatment strategies, medication changes and patient satisfaction scores were recorded. RESULTS: A total of 503 patients were recruited. Some 36.2% had changes made to treatment, and 88.8% of these had treatment escalation. Overall, the mean PsAID-12 score was higher for patients with treatment escalation; increase in PSAID-12 score is associated with increased odds of treatment escalation (odds ratio 1.58; P 
ISSN:1462-0324